Streetbeat News

Stock Prices

HIMS

Hims & Hers Health (NYSE:HIMS) reported Q2 2024 earnings per share (EPS) of $0.06, surpassing the analyst estimate of $0.03. The company also reported sales of $315.648 million, exceeding the estimate of $299.942 million. This represents a significant improvement from the same period last year, with EPS increasing by 300% and sales by 51.82%.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:08 pm

ZI

ZoomInfo Technologies (NASDAQ:ZI) reported Q2 2024 adjusted EPS of $0.17, missing the analyst estimate of $0.23 by 26.09%. The company also reported sales of $291.50 million, missing the estimate of $307.73 million by 5.27%. This represents a 5.54% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:07 pm

LCID

Lucid Group (NASDAQ:LCID) reported Q2 2024 adjusted EPS of $(0.29), missing the $(0.26) estimate, but achieved sales of $200.6M, beating the $192.059M estimate. Sales increased by 32.96% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:07 pm

ACM

AECOM (NYSE:ACM) reported Q3 earnings of $1.16 per share, beating the analyst estimate of $1.13. Sales were $4.15 billion, surpassing the $3.98 billion estimate. This represents a 23.4% increase in earnings and a 13.29% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:07 pm

CRSP

CRISPR Therapeutics (NASDAQ:CRSP) reported Q2 2024 adjusted EPS of $(1.49), beating the estimate of $(1.52). However, sales were $517K, significantly missing the $3.54M estimate and representing a 99.26% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:07 pm

LCID

Lucid Group has announced a $1.5 billion commitment from a public investment fund. This significant investment is expected to bolster the company's financial position and support its growth initiatives.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:06 pm

ADUS

Addus HomeCare (NASDAQ:ADUS) reported Q2 2024 adjusted EPS of $1.35, beating the $1.21 estimate. Sales were $286.922M, surpassing the $285.007M estimate. EPS increased by 26.17% YoY, and sales grew by 10.36% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:06 pm

AAPL

AMZN

GOOGL

META

NVDA

SPY

Veteran Wall Street analyst Ed Yardeni counters recession fears, stating that the weak July employment report does not indicate a recession. Yardeni expects stronger employment data in August and has raised his year-end S&P 500 target to 5,800 points. He also predicts the S&P 500, tracked by SPDR S&P 500 ETF Trust (SPY), will reach 8,400 points by the end of the decade. Yardeni believes the market's adverse reaction to the jobs report was exaggerated and influenced by speculators covering carry trades in major tech stocks.

Portfolio Pulse from Piero Cingari

August 05, 2024 | 8:05 pm

VNOM

Viper Energy (NASDAQ:VNOM) reported Q2 2024 adjusted EPS of $0.61, beating the estimate of $0.56. Sales were $216.708 million, surpassing the $216.238 million estimate and marking a 34.78% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:04 pm

HPK

HighPeak Energy (NASDAQ:HPK) reported Q2 2024 adjusted EPS of $0.28, missing the $0.50 estimate. Sales were $275.266M, slightly below the $277.939M estimate but up 14.33% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:04 pm